Steven Mayo

Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial

Richard E. Thompson, Michael Rosenblum, Gayane Yenokyan et al. · The Lancet · 2019 · 899 citations · Full text

Medicine, Neurosurgery, Surgery +15

Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial

Daniel F. Hanley, Karen Lane, Nichol McBee et al. · The Lancet · 2017 · 488 citations · Full text

Medicine, Neurology, Cerebrovascular Neurosurgery +12

Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial

Daniel F. Hanley, Richard E. Thompson, John Muschelli et al. · The Lancet Neurology · 2016 · 393 citations · Full text

Medicine, Neurosurgery, Surgery +12

Surgical Performance Determines Functional Outcome Benefit in the Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation (MISTIE) Procedure

Issam A. Awad, Sean P. Polster, Julián Carrión‐Penagos et al. · Neurosurgery · 2019 · 144 citations · Full text

Medicine, Neurosurgery, Surgery +17

A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Phase III Study of Clot Lysis Evaluation of Accelerated Resolution of Intraventricular Hemorrhage (CLEAR III)

Wendy Ziai, Stanley Tuhrim, Karen Lane et al. · International Journal of Stroke · 2013 · 113 citations · Full text

Medicine, Neurosurgery, Pharmacotherapy +15